These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Brain morphological alterations and cellular metabolic changes in patients with generalized anxiety disorder: A combined DARTEL-based VBM and (1)H-MRS study. Moon CM; Jeong GW Magn Reson Imaging; 2016 May; 34(4):429-36. PubMed ID: 26708039 [TBL] [Abstract][Full Text] [Related]
5. Methamphetamine users in sustained abstinence: a proton magnetic resonance spectroscopy study. Nordahl TE; Salo R; Natsuaki Y; Galloway GP; Waters C; Moore CD; Kile S; Buonocore MH Arch Gen Psychiatry; 2005 Apr; 62(4):444-52. PubMed ID: 15809412 [TBL] [Abstract][Full Text] [Related]
6. Proton MR spectroscopy: higher right anterior cingulate N-acetylaspartate/choline ratio in Asperger syndrome compared with healthy controls. Oner O; Devrimci-Ozguven H; Oktem F; Yagmurlu B; Baskak B; Munir KM AJNR Am J Neuroradiol; 2007 Sep; 28(8):1494-8. PubMed ID: 17846198 [TBL] [Abstract][Full Text] [Related]
7. Single voxel proton magnetic resonance spectroscopy in women with and without intimate partner violence-related posttraumatic stress disorder. Seedat S; Videen JS; Kennedy CM; Stein MB Psychiatry Res; 2005 Aug; 139(3):249-58. PubMed ID: 16055312 [TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance spectroscopy in social phobia: preliminary findings. Davidson JR; Krishnan KR; Charles HC; Boyko O; Potts NL; Ford SM; Patterson L J Clin Psychiatry; 1993 Dec; 54 Suppl():19-25. PubMed ID: 8276746 [TBL] [Abstract][Full Text] [Related]
9. Metabolic change in the right dorsolateral prefrontal cortex and its correlation with symptom severity in patients with generalized anxiety disorder: Proton magnetic resonance spectroscopy at 3 Tesla. Moon CM; Kang HK; Jeong GW Psychiatry Clin Neurosci; 2015 Jul; 69(7):422-30. PubMed ID: 25611853 [TBL] [Abstract][Full Text] [Related]
10. 1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: effects of 12 weeks of sertraline treatment on brain metabolites. Tükel R; Aydın K; Ertekin E; Özyıldırım SŞ; Barburoğlu M Eur Arch Psychiatry Clin Neurosci; 2015 Apr; 265(3):219-26. PubMed ID: 25256264 [TBL] [Abstract][Full Text] [Related]
11. Cortical neurochemistry in euthymic patients with bipolar I disorder. Scherk H; Backens M; Schneider-Axmann T; Usher J; Kemmer C; Reith W; Falkai P; Gruber O World J Biol Psychiatry; 2009; 10(4):285-94. PubMed ID: 19921970 [TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance spectroscopy in school-aged autistic children. Vasconcelos MM; Brito AR; Domingues RC; da Cruz LC; Gasparetto EL; Werner J; Gonçalves JP J Neuroimaging; 2008 Jul; 18(3):288-95. PubMed ID: 18304036 [TBL] [Abstract][Full Text] [Related]
13. [Proton magnetic resonance spectroscopy and diffusion tensor imaging study of first-episode patients with positive symptoms of schizophrenia]. Jia YB; Wang Y; Ling XY; Zhong SM; Huang L Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):374-8. PubMed ID: 22445987 [TBL] [Abstract][Full Text] [Related]
14. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment. Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281 [TBL] [Abstract][Full Text] [Related]
15. Proton magnetic resonance spectroscopy of the anterior cingulate region in schizophrenia. Deicken RF; Zhou L; Schuff N; Weiner MW Schizophr Res; 1997 Oct; 27(1):65-71. PubMed ID: 9373896 [TBL] [Abstract][Full Text] [Related]
16. Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study. Ciurleo R; Bonanno L; Di Lorenzo G; Bramanti P; Marino S Neurosci Lett; 2015 Jul; 599():55-60. PubMed ID: 26007705 [TBL] [Abstract][Full Text] [Related]
17. Metabolite profile in the basal ganglia of children with cerebral palsy: a proton magnetic resonance spectroscopy study. Kulak W; Sobaniec W; Smigielska-Kuzia J; Kubas B; Walecki J Dev Med Child Neurol; 2006 Apr; 48(4):285-9. PubMed ID: 16542516 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study. Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314 [TBL] [Abstract][Full Text] [Related]
19. N-acetylaspartate/creatine and choline/creatine ratios in the thalami, insular cortex and white matter as markers of hypertension and cognitive impairment in the elderly. Ben Salem D; Walker PM; Bejot Y; Aho SL; Tavernier B; Rouaud O; Ricolfi F; Brunotte F Hypertens Res; 2008 Oct; 31(10):1851-7. PubMed ID: 19015591 [TBL] [Abstract][Full Text] [Related]
20. Progressive decrease of N-acetylaspartate to total creatine ratio in the pregenual anterior cingulate cortex in patients with major depressive disorder: longitudinal 1H-MR spectroscopy study. Tae WS; Kim SS; Lee KU; Nam EC; Koh SH Acta Radiol; 2014 Jun; 55(5):594-603. PubMed ID: 24031048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]